GlaxoSmith-C-H-L Stock/Share Prices, Buy and Sell GlaxoSmith-C-H-L BSE Stocks – AxisDirect.

GlaxoSmithkline Consumer Healthcare Ltd NSE / BSE
FMCG, Large Cap

18 Jun 2018 | 02:57 PM

6,170.00

-4.80 (-0.08%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Outperforms Index

15.11%

Return (1Y)

Beaten S&P BSE FMCG Sector by 3.82%
More Volatile

1.42%

Standard Deviation (1Y)

Higher than S&P BSE FMCG Sector by 0.58%
Not so consistent

6/12

Months

underperformed S&P BSE FMCG Sector
AxisDirect View

No View

52 Week High-Low

6,888

4,856

News & Announcements

GlaxoSmithkline Consumer Healthcare Ltd is up for a third straight session today
24 days ago

GlaxoSmithkline Consumer Healthcare Ltd is up for a third straight session today

25 - May - 2018 12:00 AM | 24 days ago

GlaxoSmithkline Consumer Healthcare Ltd is up for a third straight session today. The stock is quoting at Rs 6603, up 4.58% on the day as on 12:59 IST on the NSE. The benchmark NIFTY is up around 0.51% on the day, quoting at 10567.85. The Sensex is at 34815.69, up 0.44%. GlaxoSmithkline Consumer Healthcare Ltd has gained around 11.06% in last one month.
Meanwhile, Nifty FMCG index of which GlaxoSmithkline Consumer Healthcare Ltd is a constituent, has gained around 0.73% in last one month and is currently quoting at 28500.25, up 0.18% on the day. The volume in the stock stood at 42789 shares today, compared to the daily average of 15028 shares in last one month.
The PE of the stock is 37.85 based on TTM earnings ending March 18.
Powered by Capital Market - Live News
Board of Glaxosmithkline Consumer Healthcare recommends dividend
35 days ago

Board of Glaxosmithkline Consumer Healthcare recommends dividend

14 - May - 2018 12:00 AM | 35 days ago

Glaxosmithkline Consumer Healthcare announced that the Board of Directors of the Company at its meeting held on 11 May 2018, inter alia, has recommended the final dividend of Rs.75 per share (i.e.750%), subject to approval of the shareholders.
Powered by Capital Market - Live News

GlaxoSmithkline Consumer Healthcare standalone net profit rises 20.43% in the March 2018 quarter

36 days ago

Glaxosmithkline Consumer Healthcare to consider Accounts
45 days ago

Glaxosmithkline Consumer Healthcare to consider Accounts

03 - May - 2018 12:00 AM | 45 days ago

Glaxosmithkline Consumer Healthcare will hold a meeting of the Board of Directors of the Company on 11 May 2018, inter alia, to consider and approve, the audited Financial Results of the Bank for the quarter / year ended on March 31, 2018 and to recommend dividend for the year 2017-18, if any.
Powered by Capital Market - Live News

Price vs Volume

1D
5D
1M
3M
1Y
3Y
5Y
MAX

Stock Trivia

FII shareholding in GlaxoSmithkline Consumer Healthcare Ltd has increased by 10.72% since past 3 Months
MF shareholding in GlaxoSmithkline Consumer Healthcare Ltd has decreased by -6.93% since past 3 Months
FII shareholding in GlaxoSmithkline Consumer Healthcare Ltd has increased by 3.8% since past 1 Year
MF shareholding in GlaxoSmithkline Consumer Healthcare Ltd has decreased by -11.67% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

v5.5.0-S80